Editas Medicine Inc

EDIT

$58.71

+97.4% (1 year change)

Market Cap

$4.24 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$27.01 - $99.95

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

-25.42x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $4.24 Billion
Enterprise Value $3.63 Billion
Dividend Yield $0.00 (0.0%)
1 Year Return +97.4%
52-Week High $99.95
52-Week Low $27.01
Beta 1.6
Outstanding Shares 68.3 Million
Avg 30 Day Volume 1.45 Million

Valuation

P/E Ratio -25.42
PEG -50.46
Earnings per Share -$2.58
Price to Sales Ratio 58.71
Price to Book Ratio 7.34
Revenue to Enterprise Value 39.63
EBIT to Enterprise Value -24.99
Total Debt to Enterprise Value 0.0
Debt to Equity 0.0

Profitability

Revenue $91.5 Million
Gross Profit $91.5 Million
EBIT -$145 Million
Net Income -$135 Million
Profit Margin -147.51%
Quarterly Earnings Growth (YoY) +50.4%
Return on Equity -22.01%
Return on Assets -17.86%
Return on Invested Capital -21.03%

News

CRISPR Technology Global Market Report 2021: COVID-19 Growth And Change To 2030

CRISPR Technology Global Market Report 2021: COVID-19 Growth And Change To 2030

Major players in the CRISPR technology market are Thermo Fisher Scientific, GenScript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Horizon Discovery Plc. , Integrated DNA Technolog...

Intrado Digital Media Intrado Digital Media, 1 day ago
Editas Medicine (EDIT) CEO, Jim Mullen Presents at Morgan Stanley 19th Annual Healthcare Conference - Company Call Transcript

Editas Medicine (EDIT) CEO, Jim Mullen Presents at Morgan Stanley 19th Annual Healthcare Conference - Company Call Transcript

No summary available.

Seeking Alpha Seeking Alpha, 11 days ago
Aadi Bioscience Appoints Emma Reeve to its Board of Directors

Aadi Bioscience Appoints Emma Reeve to its Board of Directors

LOS ANGELES, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Aadi) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cance...

Intrado Digital Media Intrado Digital Media, 12 days ago